NICE tackles CT data issue
This article was originally published in Scrip
Executive Summary
The UK health technology assessment body NICE has made changes to its policy on assessing drugs and said that it will approach European regulators for access to clinical trial data if pharmaceutical companies fail to supply this data in a timely manner.